Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor

Human Molecular Genetics

Volumn 14, Issue 12, 2005, Pages 1699-1708

  Erker, Laura ^a,b   Schubert, Ralf ^a,b,e   Yakushiji, Hiroyuki ^a,b,f   Barlow, Carrolee ^c,g   Larson, Denise ^c   Mitchell, James B ^d   Wynshaw Boris, Anthony ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e GOETHE UNIVERSITY   (Germany)

^f Taku Hospital   (Japan)

^g BrainCells Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; HISTONE H2A; PHOSPHATIDYLINOSITOL 3 KINASE; PLACEBO; PROTEIN P21; PROTEIN P53; SERINE; TEMPOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER; CANCER PREVENTION; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; DRUG SPECIFICITY; ENZYME INHIBITION; IN VITRO STUDY; LIFESPAN; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THYMOCYTE; TUMOR SUPPRESSOR GENE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIOXIDANTS; APOPTOSIS; ATAXIA TELANGIECTASIA; CELL CYCLE PROTEINS; CHEMOPREVENTION; CYCLIC N-OXIDES; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; GENES, TUMOR SUPPRESSOR; LONGEVITY; MICE; MICE, KNOCKOUT; NEOPLASMS, EXPERIMENTAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; REACTIVE OXYGEN SPECIES; SERINE; SPIN LABELS; THYMUS GLAND; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

ATAXIA TELANGIECTASIA;

EID: 21244453856     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddi181     Document Type: Article

References (67)

1. Bailar, J.C. and Gornik, H.L. (1997) Cancer undefeated. N. Engl. J. Med., 336, 1569-1574.
2. Steinmetz, K.A. and Potter, J.D. (1991) Vegetables, fruit, and cancer. II. Mechanisms. Cancer Causes Control, 2, 429-442.
3. Tamimi, R.M., Lagiou, P., Adami, H.O. and Trichopoulos, D. (2002) Prospects for chemoprevention of cancer. J. Intern. Med., 251, 286-300.
4. McCullough, M. and Giovannucci, E. (2004) Diet and cancer prevention. Oncogene, 23, 6349-6364.
5. Schubert, R., Erker, L., Barlow, C., Yakushiji, H., Larson, D., Russo, A., Mitchell, J.B. and Wynshaw-Boris, A. (2004) Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice. Hum. Mol. Genet., 13, 1793-1802.
6. Mitchell, J.B., Xavier, S., DeLuca, A.M., Sowers, A.L., Cook, J.A., Krishna, M.C., Hahn, S.M. and Russo, A. (2003) A low molecular weight antioxidant decreases weight and lowers tumor incidence. Free Radic. Biol. Med., 34, 93-102.
7. Barlow, C., Dennery, P.A., Shigenaga, M.K., Smith, M.A., Morrow, J.D., Roberts, L.J., II, Wynshaw-Boris, A. and Levine, R.L. (1999) Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc. Natl Acad. Sci. USA, 96, 9915-9919.
8. Kamsler, A., Daily, D., Hochman, A., Stern, N., Shiloh, Y., Rotman, G. and Barzilai, A. (2001) Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice. Cancer Res., 61, 1849-1854.
9. Rotman, G. and Shiloh, Y. (1997) Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress? Bioessays, 19, 911-917.
10. Browne, S.E., Roberts, L.J., II, Dennery, P.A., Doctrow, S.R., Beal, M.F., Barlow, C. and Levine, R.L. (2004) Treatment with a catalytic antioxidant corrects the neurobehavioral defect in ataxia-telangiectasia mice. Free Radic. Biol. Med., 36, 938-942.
11. Purdie, C.A., Harrison, D.J., Peter, A., Dobbie, L., White, S., Howie, S.E., Salter, D.M., Bird, C.C., Wyllie, A.H., Hooper, M.L. et al. (1994) Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene, 9, 603-609.
12. Jacks, T., Remington, L., Williams, B.O., Schmitt, E.M., Halachmi, S., Bronson, R.T. and Weinberg, R.A. (1994) Tumor spectrum analysis in p53-mutant mice. Curr. Biol., 4, 1-7.
13. Shiloh, Y. (2003) ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer, 3, 155-168.
14. Kastan, M.B. and Lim, D.S. (2000) The many substrates and functions of ATM. Nat. Rev. Mol. Cell. Biol. 1, 179-186.
15. Khosravi, R., Maya, R., Gottlieb, T., Oren, M., Shiloh, Y. and Shkedy, D. (1999) Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc. Natl Acad. Sci. USA, 96, 14973-14977.
16. Melchionna, R., Chrn, X.B., Blasina, A. and McGowan, C.H. (2000) Threonine 68 is required for radiation-induced phosphorylation and activation of Cds1. Nat. Cell Biol., 2, 762-765.
17. Appella, E., Nagaich, A.K., Zhurkin, V.B. and Harrington, R.E. (1998) Analysis of the interaction between the p53 binding domain and the p21/CiP1 DNA response element: a novel architectural organization. J. Protein Chem., 17, 527-528.
18. Selivanova, G. and Wiman, K.G. (1995) p53: a cell cycle regulator activated by DNA damage. Adv. Cancer Res., 66, 143-180.
19. Xie, G., Habbersett, R.C., Jia, Y., Peterson, S.R., Lehnert, B.E., Bradbury, E.M. and D'Anna, J.A. (1998) Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints. Oncogene, 16, 721-736.
20. El-Deiry, W.S. (1998) p21/p53, cellular growth control and genomic integrity. Curr. Top. Microbiol. Immunol., 227, 121-137.
21. Canman, C.E., Lim, D.S., Cimprich, K.A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M.B. and Siliciano, J.D. (1998) Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science, 281, 1677-1679.
22. Brown, E.J. and Baltimore, D. (2000) ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev., 14, 397-402.
23. Brumbaugh, K.M., Otterness, D.M., Geisen, C., Oliveira, V., Brognard, J., Li, X., Lejeune, F., Tibbetts, R.S., Maquat, L.E. and Abraham, R.T. (2004) The mRNA surveillance protein hSMG-1 functions in genotoxic stress response pathways in mammalian cells. Mol. Cell, 14, 585-598.
24. Siliciano, J.D., Canman, C.E., Taya, Y., Sakaguchi, K., Appella, E. and Kastan, M.B. (1997) DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev., 11, 3471-3481.
25. Tibbetts, R.S., Brumbaugh, K.M., Williams, J.M., Sarkaria, J.N., Cliby, W.A., Shieh, S.Y., Taya, Y., Prives, C. and Abraham, R.T. (1999) A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev., 13, 152-157.
26. Huang, L.C., Clarkin, K.C. and Wahl, G.M. (1996) p53-dependent cell cycle arrests are preserved in DNA-activated protein kinase-deficient mouse fibroblasts. Cancer Res., 56, 2940-2944.
27. Gurley, K.E. and Kemp, C.J. (1996) p53 induction, cell cycle checkpoints, and apoptosis in DNAPK-deficient scid mice. Carcinogenesis, 17, 2537-2542.
28. Ito, K., Nakazato, T., Yamato, K., Miyakawa, Y., Yamada, T., Hozumi, N., Segawa, K., Ikeda, Y. and Kizaki, M. (2004) Induction of apoptosis in leukemic cells by homovanillic acid derivative, capsaicin, through oxidative stress: implication of phosphorylation of p53 at Ser-15 residue by reactive oxygen species. Cancer Res., 64, 1071-1078.
29. Gariboldi, M.B., Lucchi, S., Caserini, C., Supino, R., Oliva, C. and Monti, E. (1998) Antiproliferative effect of the piperidine nitroxide TEMPOL on neoplastic and nonneoplastic mammalian cell lines. Free Radic. Biol. Med., 24, 913-923.
30. Cheng, W.H., Zheng, X., Quimby, F.R., Roneker, C.A. and Lei, X.G. (2003) Low levels of glutathione peroxidase 1 activity in selenium-deficient mouse liver affect c-Jun N-terminal kinase activation and p53 phosphorylation on Ser-15 in pro-oxidant-induced aponecrosis. Biochem. J., 370, 927-934.
31. Barlow, C., Hirotsune, S., Paylor, R., Liyanage, M., Eckhaus, M., Collins, F., Shiloh, Y., Crawley, J.N., Ried, T., Tagle, D. et al. (1996) Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell, 86, 159-171.
32. Pugh, T.D., Oberley, T.D. and Weindruch, R. (1999) Dietary intervention at middle age: caloric restriction but not dehydroepiandrosterone sulfate increases lifespan and lifetime cancer incidence in mice. Cancer Res., 59, 1642-1648.
33. Hursting, S.D., Perkins, S.N., Brown, C.C., Haines, D.C. and Phang, J.M. (1997) Calorie restriction induces a p53-independent delay of spontaneous carcinogenesis in p53-deficient and wild-type mice. Cancer Res., 57, 2843-2846.
34. Berrigan, D., Perkins, S.N., Haines, D.C. and Hursting, S.D. (2002) Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice. Carcinogenesis, 23, 817-822.
35. Patel, A.C., Nunez, N.P., Perkins, S.N., Barrett, J.C. and Hursting, S.D. (2004) Effects of energy balance on cancer in genetically altered mice. J. Nutr., 134, 3394S-3398S.
36. Burow, S. and Valet, G. (1987) Flow-cytometric characterization of stimulation, free radical formation, peroxidase activity and phagocytosis of human granulocytes with 2,7-dichlorofluorescein (DCF). Eur. J. Cell Biol., 43, 128-133.
37. Watanabe, S. (1998) In vivo fluorometric measurement of cerebral oxidative stress using 2′-7′-dichlorofluorescein (DCF). Keio J. Med., 47, 92-98.
38. Melov, S. (2002) Therapeutics against mitochondrial oxidative stress in animal models of aging. Ann. N. Y. Acad. Sci., 959, 330-340.
39. Mossmann, T. (1983) Rapid colorimetric assay for cellular growth survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55-63.
40. Stiff, T., O'Driscoll, M., Rief, N., Iwabuchi, K., Lobrich, M. and Jeggo, P.A. (2004) ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res., 64, 2390-2396.
41. Hariharan, P.V., Eleczko, S., Smith, B.P. and Paterson, M.C. (1981) Normal rejoining of DNA strand breaks in ataxia telangiectasia fibroblast lines after low x-ray exposure. Radiat. Res., 86, 589-597.
42. Khanna, K.K., Lavin, M.F., Jackson, S.P. and Mulhern, T.D. (2001) ATM, a central controller of cellular responses to DNA damage. Cell Death Differ., 8, 1052-1065.
43. Burma, S., Chen, B.P., Murphy, M., Kurimasa, A. and Chen, D.J. (2001) ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem., 276, 42462-42467.
44. Rosenzweig, K.E., Youmell, M.B., Palayoor, S.T. and Price, B.D. (1997) Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay. Clin. Cancer Res., 3, 1149-1156.
45. Izzard, R.A., Jackson, S.P. and Smith, G.C. (1999) Competitive and noncompetitive inhibition of the DNA-dependent protein kinase. Cancer Res., 59, 2581-2586.
46. Burdon, R.H. (1995) Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic. Biol. Med., 18, 775-794.
47. Suh, Y.A., Arnold, R.S., Lassegue, B., Shi, J., Xu, X.X., Sorescu, D., Chung, A.B., Griendling, K.K. and Lambeth, J.D. (1999) Cell transformation by the superoxide generating oxidase Mox1. Nature, 401, 79-82.
48. 2 for platelet-derived growth factor signal transduction. Science, 270, 296-299.
49. Sundaresan, M., Yu, Z.X., Ferrans, V.J., Sulciner, D.J., Gutkind, J.S., Irani, K., Godschmidt Clermont, P.J. and Finkel, T. (1996) Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. Biochem. J., 318.
50. Irani, K., Herzlinger, S. and Finkel, T. (1994) Ras proteins regulate multiple mitogenic pathways in A10 vascular smooth muscle cells. Biochem. Biophys. Res. Commun., 202, 1252-1258.
51. Finkel, T. and Holbrook, N.J. (2000) Oxidants, oxidative stress and the biology of ageing. Nature, 408, 239-247.
52. Jackson, A.L. and Loeb, L.A. (2001) The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat. Res., 477, 7-21.
53. Benitez-Bribiesca, L. and Sanchez-Suarez, P. (1999) Oxidative damage, bleomycin, and gamma radiation induce different types of DNA strand breaks in normal lymphocytes and thymocytes. A comet assay study. Ann. N. Y. Acad. Sci., 887, 133-149.
54. Pagano, G., Korkina, L.G., Brunk, U.T., Chessa, L., Degan, P., del Principe, D., Kelly, F.J., Malorni, W., Pallardo, F., Pasquier, C. et al. (1998) Congenital disorders sharing oxidative stress and cancer proneness as phenotypic hallmarks: prospects for joint research in pharmacology. Med. Hypotheses, 51, 253-266.
55. Hristozov, D., Gadjeva, V., Vlaykova, T. and Dimitrov, G. (2001) Evaluation of oxidative stress in patients with cancer. Arch. Physiol. Biochem., 109, 331-336.
56. Schwartz, J.L., Antoniades, D.Z. and Zhao, S. (1993) Molecular and biochemical reprogramming of oncogenesis through the activity of prooxidants and antioxidants. Ann. N. Y. Acad. Sci., 686, 262-278.
57. Pozo-Guisado, E., Lorenzo-Benayas, M.J. and Fernandez-Salguero, P.M. (2004) Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation. Int. J. Cancer, 109, 167-173.
58. Gariboldi, M.B., Rimoldi, V., Supino, R., Favini, E. and Monti, E. (2000) The nitroxide tempol induces oxidative stress, p21 (WAF1/CIP1), and cell death in HL60 cells. Free Radic. Biol. Med., 29, 633-641.
59. Denning, G., Jamieson, L., Maquat, L.E., Thompson, E.A. and Fields, A.P. (2001) Cloning of a novel phosphatidylinositol kinase-related kinase: characterization of the human SMG-1 RNA surveillance protein. J. Biol. Chem., 276, 22709-22714.
60. Yamashita, A., Ohnishi, T., Kashima, I., Taya, Y. and Ohno, S. (2001) Human SMG-1, a novel phosphatidylinositol 3-kinase-related protein kinase, associates with components of the mRNA surveillance complex and is involved in the regulation of nonsense-mediated mRNA decay. Genes Dev., 15, 2215-2228.
61. Sugimoto, K., Toyoshima, H., Sakai, R., Miyagawa, K., Hagiwara, K., Ishikawa, F., Takaku, F., Yazaki, Y. and Hirai, H. (1992) Frequent mutations in the p53 gene in human myeloid leukemia cell lines. Blood, 79, 2378-2383.
62. Miyashita, T. and Reed, J.C. (1995) Tumor suppressor p53 is a direct transcriptional activator of teh human bax gene. Cell, 80, 293 -299.
63. Gartel, A. and Tyner, A. (2002) The role of cyclin-dependent kinase inhibitor p21 in apoptosis. Mol. Cancer Ther., 1, 639-649.
64. Liyanage, M., Weaver, Z., Barlow, C., Coleman, A., Pankratz, D.G., Anderson, S., Wynshaw-Boris, A. and Ried, T. (2000) Abnormal rearrangement within the alpha/delta T-cell receptor locus in lymphomas from Atm-deficient mice. Blood, 96, 1940-1946.
65. Singhal, A.B., Wang, X., Sumii, T., Mori, T. and Lo, E.H. (2002) Effects of normobaric hyperoxia in a rat model of focal cerebral ischemia-reperfusion. J. Cereb. Blood Flow Metab., 22, 861-868.
66. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press.
67. Placidi, L., De Meo, M., Gosselin, G., Imbach, J.L., Bryant, M.L., Dumenil, G. and Sommadossi, J.P. (2001) Evaluation of the mutagenic and genotoxic activities of anti-hepatitis B analogs of beta-L-adenosine by the Ames test and the Comet assay. Antiviral Res., 50, 139-145.